http://dana.org/news/brainwork/detail.aspx?id=35524
The race is on to create the best nanomedicine approach for brain cancer. Julia Ljubimona, who directs the research of nanomedicine at Cedars-Sinai Medical Center in Los Angeles, tells me she can’t comment on other people’s work in the field: “It is very competitive.” One nanomedicine company based in Germany refuses to talk to reporters "until next year.”
Perhaps this secrecy is because there is a lot to be gained by developing a new nanomedicine to combat brain cancer (as well as other cancers). Brain cancers are among the most difficult cancers to treat; almost all involve surgery to remove the bulk of the tumor followed by chemotherapy or radiotherapy to remove the last traces of cancer cells.
Gliobastoma and medulloblastoma are the most common brain cancers for adults and children, respectively. Doctors call these brain tumors “aggressive” because they are so deadly: After treatment, people with gliobastoma survive at a median of five more months. Of children with medulloblastoma, 70 percent to 80 percent survive to five years or more after treatment.
More at link.
No comments:
Post a Comment